| Financial Year |
March 31 2023 |
| Monetary Funds |
16,427,578.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
105,961,183.11 |
| Advances to Suppliers |
4,883,578.81 |
| Other Receivables |
357,237,590.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,257,749.46 |
| Dividend Receivable |
-- |
| Inventories |
9,809,547.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,003,456.70 |
| Total Current Assets |
514,028,934.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
79,317,173.50 |
| Investment Properties |
697,834,202.00 |
| Fixed Assetes |
213,820,651.89 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,065,145.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,632,653.62 |
| Deferred Income Tax Assets |
99,902,953.37 |
| Other Non-Current Assets |
3,977,005.31 |
| Sub-Total of Non-Current Assets |
1,283,218,432.23 |
| Total Assets |
1,797,247,366.47 |
| Short-Term Loans |
251,707,040.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
19,815,022.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
658,569.45 |
| Taxes Payable |
97,102,601.99 |
| Interest Payable |
26,480,299.44 |
| Dividend Payable |
-- |
| Other payables |
68,256,588.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
40,157.55 |
| Sub-Total of Current Liabilities |
437,888,884.88 |
| Long-term Loans |
187,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
77,574,857.11 |
| Deferred Income Tax Liabilities |
108,016,332.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
373,137,523.31 |
| Total Liabilities |
811,026,408.19 |
| Paid-In Capital(Or Share Stock) |
1,374,669,616.00 |
| Capital Surplus |
109,487,395.17 |
| Surplus Reserve |
86,630,745.18 |
| LESS:Treasury Stock |
3,609,050.00 |
| Undistributed Profits |
-563,372,063.88 |
| Minority Stockholder's Interest |
-7,845,623.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
994,066,582.11 |
| Owner's Equity（Stockholder's Equity） |
986,220,958.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,797,247,366.47 |
